ZTS Zoetis Inc

Price (delayed)

$161.34

Market cap

$76.68B

P/E Ratio

46.1

Dividend/share

$0.85

EPS

$3.5

Enterprise value

$80.89B

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights

ZTS's equity is up by 35% year-on-year and by 21% since the previous quarter
Zoetis's EPS has increased by 15% YoY and by 2.9% QoQ
Zoetis's quick ratio has decreased by 29% YoY and by 19% QoQ
The P/E is 20% higher than the 5-year quarterly average of 38.5 and 12% higher than the last 4 quarters average of 41.1

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
475.27M
Market cap
$76.68B
Enterprise value
$80.89B
Valuations
Price to earnings (P/E)
46.1
Price to book (P/B)
21.28
Price to sales (P/S)
11.73
EV/EBIT
36.06
EV/EBITDA
30.14
EV/Sales
12.36
Earnings
Revenue
$6.54B
EBIT
$2.24B
EBITDA
$2.68B
Free cash flow
$1.52B
Per share
EPS
$3.5
Free cash flow per share
$3.2
Book value per share
$7.58
Revenue per share
$13.76
TBVPS
$19.43
Balance sheet
Total assets
$13.73B
Total liabilities
$10.12B
Debt
$7.86B
Equity
$3.6B
Working capital
$4.36B
Liquidity
Debt to equity
2.18
Current ratio
2.82
Quick ratio
1.94
Net debt/EBITDA
1.57
Margins
EBITDA margin
41%
Gross margin
69.6%
Net margin
25.4%
Operating margin
34.3%
Efficiency
Return on assets
13.3%
Return on equity
55.2%
Return on invested capital
21.2%
Return on capital employed
19.8%
Return on sales
34.3%
Dividend
Dividend yield
0.53%
DPS
$0.85
Payout ratio
24.3%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
-1.22%
1 week
-0.14%
1 month
0.39%
1 year
18.36%
YTD
-2.51%
QTD
-2.51%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$6.54B
Gross profit
$4.56B
Operating income
$2.24B
Net income
$1.66B
Gross margin
69.6%
Net margin
25.4%
The net income has grown by 14% YoY and by 2.8% from the previous quarter
Zoetis's operating income has increased by 12% YoY and by 3.5% QoQ
The gross profit has grown by 10% YoY and by 3.1% from the previous quarter
The net margin rose by 7% YoY

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
P/E
46.1
P/B
21.28
P/S
11.73
EV/EBIT
36.06
EV/EBITDA
30.14
EV/Sales
12.36
The P/E is 20% higher than the 5-year quarterly average of 38.5 and 12% higher than the last 4 quarters average of 41.1
Zoetis's EPS has increased by 15% YoY and by 2.9% QoQ
ZTS's equity is up by 35% year-on-year and by 21% since the previous quarter
The stock's price to book (P/B) is 8% more than its 5-year quarterly average of 19.7 but 2.4% less than its last 4 quarters average of 21.8
ZTS's price to sales (P/S) is 56% higher than its 5-year quarterly average of 7.5 and 14% higher than its last 4 quarters average of 10.3
ZTS's revenue is up by 6% YoY and by 3.2% QoQ

Efficiency

How efficient is Zoetis business performance
The company's return on equity fell by 9% YoY and by 5% QoQ
ZTS's ROIC is up by 8% YoY and by 2.4% QoQ
Zoetis's return on sales has increased by 4.9% YoY
ZTS's return on assets is down by 2.2% since the previous quarter

Dividends

What is ZTS's dividend history
DPS
$0.85
Dividend yield
0.53%
Payout ratio
24.3%
Recent dividends

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 36% greater than its total liabilities
The company's current ratio fell by 36% YoY and by 19% QoQ
Zoetis's quick ratio has decreased by 29% YoY and by 19% QoQ
The debt is 118% higher than the equity
ZTS's equity is up by 35% year-on-year and by 21% since the previous quarter
Zoetis's debt to equity has decreased by 17% QoQ and by 12% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.